​

​

Aevolve is a platform that supports global medical, biotech, and life science innovation from the research and development stage to full-scale commercialization. Utilizing blockchain technology, their innovation network, BioSpheres, seamlessly connects patients, investors, and innovators around the world to facilitate increased efficacy, coordination, and cooperation. This is made possible through BioSpheres’ underlying asset, the AVEX token. Together, Aevolve, the BioSpheres Platform, and the AVEX token, facilitate the development and commercialization of treatments and technologies that would otherwise not reach market availability.

​

Visit Aevolve.health for more information.

​